Skip to content
How many times can you restart the COPD medication cycle before running out of options? Breztri Aerosphere finally controls your symptoms after years of switching inhalers, but now cost barriers threaten to force another change despite medical success.
Here’s how we help. The Rx Advocates links COPD patients to Patient Assistance Programs (PAPs) that calculate Breztri Aerosphere costs using income verification instead of retail pharmacy pricing.
Medically Reviewed by Dr. Conor Sheehy, PharmD, BCPS
Respiratory medication manufacturers maintain funding specifically for COPD patients who can’t afford triple-therapy inhalers at standard pricing. When you’re approved, you’ll access Breztri Aerosphere at substantially reduced costs, preventing financial barriers from interrupting the treatment keeping your airways open.
You provide prescription documentation and proof of household income. We handle application construction, coordination with your pulmonologist for required signatures, submission to manufacturers, and approval monitoring. Once enrolled, Breztri Aerosphere ships to your address monthly.
We link COPD patients to pharmaceutical programs that base inhaler pricing on financial reality rather than specialty medication markup.
Manufacturers evaluate applications using multiple standards. Meeting these income benchmarks strengthens your approval chances:
Income levels alone won't guarantee acceptance. Each pharmaceutical company reviews additional criteria specific to their program. Every case gets an individual assessment. Contact us to learn if you qualify.
The monthly service fee depends on the number
of medications you take. For example:
In addition to our monthly service fee, we charge a one-time enrollment fee of $35.
Our service is month-to-month, so if you’re not happy with it, you may cancel at any time
Our service fees stay constant even when Breztri Aerosphere retail prices climb. What you pay depends exclusively on medication count needing assistance:
COPD requires consistent medication use for symptom control and exacerbation prevention. We built our service for patients confronting insurance complications like formulary exclusions for triple-therapy inhalers, prior authorization denials, or tier placement making medications unaffordable.
Coupon distribution isn’t our business model. Our focus involves processing enrollment for manufacturer programs providing reliable inhaler access at prices dramatically below retail.
Coupons offer temporary savings. Programs ensure sustained affordability.
$80Â / Month
30-Day Supply
Last Updated: September 29, 2025. Actual retail prices may vary by pharmacy and location
With The Rx Advocates, patients pay a fixed monthly service fee, which depends on the number of medications covered.
Importantly, there are no hidden fees, and prices remain consistent even if retail costs fluctuate.
Purchasing Breztri Aerosphere without program help varies widely based on pharmacy and location. What you’d pay depends on factors outside your control including geographic region, which retailer you use, and your specific insurance plan coverage for respiratory medications.
Income limits typically hover around $40k for singles, $60k for couples, $100k for families. These represent rough guidelines only. Manufacturers evaluate other specific criteria requiring personalized assessment from our team.
We oversee complete enrollment and ongoing inhaler coordination by gathering pulmonologist paperwork, completing manufacturer applications correctly, and establishing delivery schedules preventing medication gaps.
Breztri Aerosphere combines budesonide, glycopyrrolate, and formoterol fumarate in a pressurized metered-dose inhaler treating COPD in adults.
How it works: Budesonide reduces airway inflammation. Glycopyrrolate relaxes and widens airways by blocking acetylcholine receptors. Formoterol relaxes airway muscles through beta-2 receptor stimulation. Together they provide comprehensive COPD symptom control.
Administration: Inhale two puffs twice daily, morning and evening. Shake inhaler before each use. Rinse mouth after inhalation to prevent thrush. Prime inhaler before first use or if unused for seven days.
Side effects:
Important warnings: Increases pneumonia risk in COPD patients. Not for acute bronchospasm or asthma treatment. Can cause oral thrush requiring mouth rinsing after use. May increase blood pressure and heart rate. Long-term steroid use can decrease bone density.
Uncontrolled COPD causes repeated exacerbations requiring hospitalization, progressive lung damage, respiratory failure, and premature death. Stopping Breztri Aerosphere because you can’t afford it means accepting worsening symptoms, frequent ER visits, and accelerated disease progression.
COPD medications pile up quickly between maintenance inhalers, rescue inhalers, and other treatments. Don’t let one medication’s cost compromise your breathing. Our team will navigate enrollment and help secure assistance available. Contact us online or call (844) 559-8332 today. Breathing shouldn’t depend on your bank account.
